Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vivier Affirms Its Legacy with First-to-Market Vitamin C Breakthrough: Serum 30


News provided by

Vivier

Sep 15, 2025, 08:59 ET

Share this article

Share toX

Share this article

Share toX

Premium pharmaceutical skincare brand, Vivier, unveils its latest innovation: Serum 30, a breakthrough Vitamin C serum clinically proven to reduce the appearance of hyperpigmentation while visibly refining texture and tone for a smoother, more radiant complexion.

NEW YORK, Sept. 15, 2025 /PRNewswire-PRWeb/ -- Premium pharmaceutical skincare brand, Vivier, unveils its latest innovation: Serum 30, a breakthrough Vitamin C serum clinically proven to reduce the appearance of hyperpigmentation while visibly refining texture and tone for a smoother, more radiant complexion.

Developed with scientific precision, Serum 30 was named for its advanced formula, which boasts a potent 30% Vitamin C concentration. This formula combines two unique forms of Vitamin C, 20% Et-VC® (3-0 Ethyl Ascorbic Acid)[1] and 10% L-Ascorbic Acid USP[2], which deliver ultimate skin-brightening results and powerful protection against damage, without compromising skin health.

"Our mission has always been to provide premium, innovation-led, science-backed products ever since we launched our first Vitamin C serum 25 years ago," says Jess Vivier, Founder of Vivier. "With the launch of Serum 30, the eighth product in our portfolio of category-defining Vitamin C serums, Vivier ushers in a new era of topical hyperpigmentation treatment by offering something truly groundbreaking and previously unattainable."

Cosmetic industry standards have historically considered 8-20% an ideal level of Vitamin C to achieve one's desired skin brightening and antioxidant protection results, largely due to the risk of potential irritation and/or increased possibility of rapid oxidation past the 20% ceiling. Serum 30 challenges convention by leveraging Vivier's patented IntraDermal System (IDS)®[3] and expertly balancing Et-VC® and L-Ascorbic Acid USP to achieve maximum potency, stability, comfort, and brightening. These results were only made possible through the use of IDS and rival those seen from Hydroquinone, a topical skin-lightening agent unavailable in the United States without a prescription, which many industry experts consider the gold standard.

Suitable for all skin types, users will benefit from visibly reduced hyperpigmentation, including dark spots, age spots, sun damage, melasma, and the prevention of new unwanted discoloration. Additional benefits users will experience are boosted collagen for reduced fine lines and wrinkles, and powerful antioxidant and anti-inflammatory support to reduce redness and the chances of rebound hyperpigmentation, making Serum 30 optimal for sensitive, reactive or post-treatment skin. The product retails for $200.00 USD and is available at vivierskin.com and through authorized skincare professionals.

[1]Et-VC® (3-0 Ethyl Ascorbic Acid) is a highly stable ethylated Vitamin C derivative that provides superior inhibition of the melanogenesis process, giving it a powerful lightening effect, while serving as a potent anti-aging, anti-inflammatory active that boosts collagen synthesis and protects skin from damage. Its lipophilic structure enables dual solubility, enhancing its ability to efficiently penetrate both hydrophilic and lipophilic layers of the skin for gentle yet potent brightening.

[2]L-Ascorbic Acid USP is the most potent, pure, and bioavailable form of Vitamin C, offering unparalleled antioxidant protection, maximum collagen-boosting benefits, and rapid brightening results thanks to its small molecular size—which enhances absorption and penetration—and its ability to act immediately without requiring conversion like stabilized derivatives.

[3]IntraDermal System (IDS)® is a proprietary delivery system that protects the Vitamin C and enhances penetration into all skin layers, with 2x more Vitamin C retention in the skin overall and 4x more in the dermis, while resisting oxidation to maintain maximum potency and consistent, visible results.

About Vivier

Vivier is a Canadian pharmaceutical grade skincare brand driven by the beauty of results - offering a range of proven formulas backed by science to prepare, target, moisturize and protect the skin. For 25 years, Vivier has championed innovative ingredients and rigorous testing, continuously dedicated towards delivering only the most exceptional results to empower individuals to look and feel their best. Vivier products are found online and in various medical and dermatology clinics throughout Canada. For more information, visit www.vivierskin.com or follow us on social media @vivierskin.

For media inquiries, please contact:

Grayson Klimek, Senior Account Manager, 1Milk2Sugars

[email protected]

Media Contact

Grayson Klimek, 1Milk2Sugars, 1 4036895958, [email protected]

SOURCE Vivier

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.